Henning Hvid

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Artificial Intelligence

Glycemic Control

Top Venues

Journal of diabetes science and technology

Toxicologic pathology

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Henning Hvid, Christian L Brand, Tina Hummelshøj, Sanne Jensen, Stephan D Bouman, Andrew Bowler, Bjarne R Poulsen, Peter Tiainen, Thorbjörn Åkertröm, Damien Demozay, Thomas Hoeg-Jensen, Camilla Ingvorsen, Thomas Å Pedersen, Jim McGuire, Thomas Egebjerg, Karen A Cappelen, Ina P Eliasen, Bo F Hansen, Stephanie Hennen, Carsten E Stidsen, Grith S Olsen, Nikolaj Kulahin Roed
Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models. Diabetologia (2022)
Tobias H Dovmark, Peter H Kvist, Anne-Marie Mølck, Henning Hvid
Quantitative Assessment of Epithelial Proliferation in Rat Mammary Gland Using Artificial Intelligence Independent of Choice of Proliferation Marker. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 70 (3) (2022)
Henning Hvid, Mikala Skydsgaard, Nikolai K Jensen, Birgitte Martine Viuff, Henrik E Jensen, Martin B Oleksiewicz, Peter H Kvist
Artificial Intelligence-Based Quantification of Epithelial Proliferation in Mammary Glands of Rats and Oviducts of Göttingen Minipigs. Toxicologic pathology 49 (4) (2020)
Henning Hvid, Tine Glendorf, Jakob Brandt, Rita Slaaby, Anne Lützen, Kim Kristensen, Bo F Hansen
Increased insulin receptor binding and increased IGF-1 receptor binding are linked with increased growth of L6hIR cell xenografts in vivo. Scientific reports 10 (1) (2020)
Henning Hvid, Jonas Kildegaard, Kim Kristensen, Trine Porsgaard, Mikkel S Jørgensen, Borja Ballarín-González, Jonas Ahnfelt-Rønne, Bo F Hansen, Erica Nishimura
Intraintestinal and Parenteral Administration of an Insulin Analogue Leads to Comparable Activation of Signaling Downstream of the Insulin Receptor in the Small Intestine. Journal of diabetes science and technology 14 (1) (2019)
Henning Hvid, Mikkel S Jørgensen, Niels Blume, Rita Slaaby, Anne Lützen, Bo F Hansen
Activation of insulin receptors and IGF-1 receptors in COLO-205 colon cancer xenografts by insulin and insulin analogue X10 does not enhance growth under normo- or hypoglycaemic conditions. Diabetologia 61 (11) (2018)